Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer

SIMPLE SUMMARY: Patients diagnosed with endometrial cancer (EC), the most common gynaecological malignancy in women worldwide, cope with a disease associated with poor prognosis and limited treatment options after first-line therapy when it reaches an advanced or metastatic stage. Lately, small-mole...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Megino-Luque, Cristina, Moiola, Cristian Pablo, Molins-Escuder, Clara, López-Gil, Carlos, Gil-Moreno, Antonio, Matias-Guiu, Xavier, Colas, Eva, Eritja, Núria
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7598629/
https://ncbi.nlm.nih.gov/pubmed/32987790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102751
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars